OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
KRPZ50

Kropz PLC

Agricultural ChemicalsVerified

Kropz PLC has an equal number of basic and diluted shares outstanding, with 1,647,367,866 shares in both categories, indicating no dilution from stock options or convertible securities at this time. However, the company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and no mention of going-concern language in the source documents. Profitability and return metrics are not available for Kropz PLC, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data makes it difficult to compare the company's performance against industry benchmarks or preferred metrics for the Agricultural Chemicals industry. Segment and geographic exposure details are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. Without this information, it is unclear whether the company is exposed to significant regional or product-specific risks. Growth trajectory data is also absent, with no outlook provided for the current or next fiscal year. The lack of revenue history and forward-looking guidance limits the ability to evaluate the company's growth potential or strategic direction. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Additionally, the absence of detailed financial disclosures limits the ability to evaluate credit risk or other operational risks. Recent events, including filings or transcripts, are not available in the provided data, which limits the ability to assess the company's recent performance or strategic developments.

30-day price · KRPZ(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyKropz PLC
TickerKRPZ.L
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Kropz PLC has an equal number of basic and diluted shares outstanding, with 1,647,367,866 shares in both categories, indicating no dilution from stock options or convertible securities at this time. However, the company's liquidity risk remains unassessed due to the absence of balance-sheet inputs and no mention of going-concern language in the source documents. Profitability and return metrics are not available for Kropz PLC, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data makes it difficult to compare the company's performance against industry benchmarks or preferred metrics for the Agricultural Chemicals industry. Segment and geographic exposure details are not disclosed in the available data, making it impossible to assess revenue concentration or geographic diversification. Without this information, it is unclear whether the company is exposed to significant regional or product-specific risks. Growth trajectory data is also absent, with no outlook provided for the current or next fiscal year. The lack of revenue history and forward-looking guidance limits the ability to evaluate the company's growth potential or strategic direction. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Additionally, the absence of detailed financial disclosures limits the ability to evaluate credit risk or other operational risks. Recent events, including filings or transcripts, are not available in the provided data, which limits the ability to assess the company's recent performance or strategic developments.
Key takeaways
  • Kropz PLC has no dilution from stock options or convertible securities at this time.
  • The company's liquidity risk remains unassessed due to missing balance-sheet data.
  • Profitability and return metrics are not available, limiting performance comparisons.
  • Segment and geographic exposure details are not disclosed, making it difficult to assess diversification.
  • Growth trajectory and recent events are not available, limiting strategic evaluation.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$0.00-$6.3M-$13.8M-$59.8M
FY-3$0.00-$98.4M-$66.6M-$126.6M
FY-2
FY-1$40.1M$1.4M$8.9M
FY0$37.2M-$19.9M-$9.6M-$10.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$190.9M$122.0M
FY-3$119.5M$46.9M
FY-2
FY-1$144.7M$54.3M
FY0$145.7M$72.6M
PeriodOCFCapExFCFSBC
FY-4-$1.7M-$42.5M-$59.8M
FY-3-$9.2M-$29.6M-$126.6M
FY-2
FY-1-$23.0M-$6.6M
FY0-$18.9M-$3.4M-$10.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricKRPZActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 04:31 UTC#5dfd6c74
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 08:59 UTCJob: 6373cde5